Watch this video of the i-Lipo on The Doctors Show.

Why i-Lipo?

• No pain, no needles, no downtime! i-Lipo is the latest body contouring system and the European winner of the prestigious ‘Victoire de la Beaute Award, Slimming Treatment of the Year, Paris’. I-Lipo is the intelligent alternative to liposuction and has many advantages compared to other systems. i-Lipo is much more affordable then surgical liposuction or other laser treatments.
• Clinical studies show that i-Lipo has comparable results that are achieved through liposuction surgery.  There is a 30% reduction in the fat layer depth just after one treatment, and more can be achieved through more sessions.  As the fat cell contents are released and excreted through the lymphatic system, immediate results can be seen after the treatment. It is recommended to do light exercise post treatment to accelerate the removal process of the released fat.
• i-Lipo targets specific problem areas. Laser pads are positioned on the targeted areas such as the upper arms, chin, abdomen, or thighs. Instead of exercise reducing overall body fat, i-Lipo can reshape individual problem areas.
• i-Lipo receives FDA approval for low level laser diode device for circumference reduction of the waist. The i-Lipo is the first direct skin contact laser device for fat reduction and body contouring.
• i-Lipo’s New Clinical Paper – France: The study was a prospective evaluation of 15 patients (12 women, 3 men) during a course of 8 i-Lipo treatment sessions over 4 weeks.  The included subjects were chosen as having a history of ‘resistant’ anatomical areas that had previously demonstrated nil improvement to regular gym exercise and diet control alone.  7 subjects had treatments on the thigh, 8 subjects had abdominal treatments.  Direct circumference measurements of treated anatomy and echography measurements of fat layer thickness were recorded. The second part of the study, histological and biological analysis was performed on human skin explants maintained in survival conditions, using light microscopy and assaying glycerol collagen synthesis levels after 5 i-Lipo simulated treatments on the tissue versus control (untreated) tissue.

Circumference Measurements:

• An average of 4.16cm was reduced from (8) abdominal treatments
• An average of 1.5cm was lost from (8) thigh treatments

Echography (Ultrasound fat thickness measurements):

• An average of 5.1mm reduction in fat layer thickness
• An average of 5.6mm reduction in fat layer thickness
• Overall, for all subjects, an average thickness reduction in adipose tissue of 18%

Reduction of Fatty tissue (Kg):

• An average of 4.8% reduction in mass of fatty tissue in the abdomen (8) treatments
• An average of 2.41% reduction in mass of fatty tissue in the thigh (8) treatments
• One subject reduced fatty tissue mass by 7.84% during their treatments (8)

Histological Analysis using Light Microscopy:

• Visible thinning of the hypodermis (fat layer)
• Reduction of average fat cell size
• Reduction of fibrosis divisions between the fat lobules
• Modification of fat cell membranes including flattening or elongation of the fat cell shape compared to the normal globular shape of filled capacity fat cells
• No observed necrosis or destruction of adjacent structures (epidermis, microvasculature, dermal collagen)

Biochemical Analysis:

• Increase in measured glycerol levels to 233.5?g/g fat in i-Lipo treatment tissue versus 177.16?g/g for control (untreated) areas (p=0.043) representing an increase of approximately 30%.
• Glycerol levels are indicative of fat release from fat stores.
• Increase in measured collagen synthesis to 46.2?g/mg tissue in i-Lipo treatment tissue versus 40.25?g/mg in control (untreated) tissue (p=0.001), representing an increase in collagen synthesis of approximately 15%.
• This collagen will act to restructure the dermis and hypodermis following shrinkage of the fatty tissue, improving the visible appearance of cellulite and potentially slowing or preventing relapse of the condition